Pharmacological adherence to oral anticoagulant and factors that influence the international normalized ratio stability;Adhesión farmacológica al anticoagulante oral y factores que influyen en la estabilidad del índice de estandarización internacional

Revista Latino-Americana de Enfermagem

Volumn 19, Issue 1, 2011, Pages 18-25

  Ávila, Christiane Wahast ^a,b   Aliti, Graziella Badin ^a   Feijó, Maria Karolina Ferreira ^a,b   Rabelo, Eneida Rejane ^b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Ambulatory; Anticoagulants; International Normalized Ratio; Monitoring

Indexed keywords

EID: 79952523323     PISSN: 01041169     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0104-11692011000100004     Document Type: Article

References (28)

1. Ansell JE, Buttarom ML, Thomas OV, Knowlton CH. Consensus guidelines for coordinated outpatient an oral anticoagulation therapy management: Anticoagulation guidelines task force. Ann Pharmacother. 1997;31:604-615.
2. Hirsh J, Fuster V, Ansell J, Halperin JL. American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy. Circulation. 2003;107:1692-1711.
3. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin k antagonist: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126 Suppl: 204S-33S.
4. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stabilitity of anticoalation for patients with unexplained variability in response to Warfarin. Blood. 2007;109(6):2419-2422.
5. Rohde LE, de Assi MC, Rabelo ER Dietary vitamin K intake and anticoagulation in elderly patients. Curr Opin Clin Nutr Metab Care. 2007;10:1-5.
6. Udall JA. Human sources and absorption of vitamin K in relation to anticoagulation stability. JAMA. 1965;194:127-129.
7. Schurgers LJ, Shearer MJ, Hamulyák K, Stöcklin E, Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose response relationships in healthy subjects. Blood. 2004;104:2682.
8. Leite SN, Vasconcellos MPC. Adesão à terapêutica medicamentosa: elementos para a discussão de conceitos e pressupostos adotados na literatura. Cad Saúde Colet. 2003; 8(3):775-782.
9. Zeolla MM, Brodeur RR, Dominelli A, Haines ST, Allie ND. Development and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge test. Ann Pharmacother. 2006;40:633-638.
10. Briggs AL, Jackson TR, Bruce S, Shapiro NL. The development and performance validation of a tool to assess patient anticoagulation knowledge. Res Social Adm Pharm. 2005;1(1):40-59.
11. Van Damme S, Van Deyk K, Moons P, Verhamme P, Budts W. Instruments to assess patient's knowledge regarding oral anticoagulation therapy: a systematic review. Eur J Cardiovasc Nurs. 2008;7 Suppl 1:21-22.
12. Shimabukuro TT, Kramer J, Mcguire M. Development and implementation of a nurse-managed anticoagulation program. J Health Qual. 2004;26(1):4-13.
13. Khan TI, Kamali F, Kesteven P, Avery P, Wynne H. The value of education and self-monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation. Br J Haematol. 2004;126(4):557-564.
14. Davis, NJ, Billet HH, Cohen HW, Arnsten JH. Impact of adherence, knowledge, and quality of life on anticoagulation control. Ann. Pharmacother. 2005;39(34):632-636.
15. Morisky DE, Green LW, Levine DM. Concuurent and predictive validity of a self-reported measure of medication adherence. Med Care.1986;24(1):67-74.
16. Dosse C, Cesarino CB, Martin JFV, Castedos MCA. Fatores associados a não adesão dos pacientes ao tratamento de hipertensão arterial. Rev. Latino-Am. Enfermagem. 2009; 17(2):201-206.
17. Esmerio FG, Souza EM, Leiria TL, Lunelli R, Moraes MA. Uso crônico de anticoagulante oral: implicações para o controle de níveis adequados. Arq. Bras. Cardiol. 2009;93(5):549-554.
18. Prado JC, Kupek E, Mion D. Validity of indirect methods to measure adherence in primary care hypertensives. J Human Hypertens. 2007;21:579-584.
19. Dzung TL, Weibert RT, Sevilla BK, Donnelly KJ, Rapaport SI. The International Normalized Ratio (INR) for Monitoring Warfarin Therapy: Reliability and Relation to Other Monitoring Methods. Ann Intern Med. 1994;120:552-558.
20. Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand J-P, et al. Improving clinical outcomes by reducing bleeding in patients with non- ST-elevation acute coronary syndromes. Eur Heart J. 2009;30(6):655-661.
21. Schmitt L, Speckman J, Ansell J. Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range. J Thromb Thrombolysis. 2003;15(3):213-216.
22. Assis MC, Rabelo ER, Ávila CW, Polanczyk CA, Rohde EL. Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial. Circulation. 2009;120:1115-1122.
23. Pautas E, Gouin-Thibault I, Debray M, Gaussem P, Siguret V. Haemorrhagic complications of vitamin k antagonists in the elderly: risk factors and management. Drugs Aging. 2006;23:13-25.
24. Holbrook A, Pereira JA, Labiris R, Mcdonald H, Douketis JD, Crowther M, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med. 2005; 165:1095-1106.
25. Chan TY. Adverse interactions between warfarin and nonsteroidal antiinflammatory drugs: mechanisms, clinical significance, and avoidance. Ann Pharmacother. 1995; 29:1274-1283.
26. Schulman S, Beyth RJ, Kearon C, Levine MN. Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6):257S-598S.
27. Levine MN, Raskob G, Beyth RJ, Kearon C, Shulman S. Hemorrhagic complications of anticoagulant treatment. Chest. 2004;126(3):287S-310S.
28. Dosse C, Cesarino CB, Martin JFV, Castedo MCA. Factors associated to patients' noncompliance with hypertension treatment. Rev. Latino-Am. Enfermagem. 2009;17(2):201-206